We are capable to formulate impressive range of bulk drugs. We provides these drugs using high quality ingredients to ensure pureness and long shelf life.

2. ●
As per research about pharmaceuticalAs per research about pharmaceutical
industries, The Indianindustries, The Indian pharma marketpharma market is 3rdis 3rd
largest in terms of volume and 13th largest inlargest in terms of volume and 13th largest in
terms of value.terms of value.
●
Continuous technological advancement andContinuous technological advancement and
exclusive cost-effective strategies, the Indianexclusive cost-effective strategies, the Indian
pharma industry has grabbed a good space inpharma industry has grabbed a good space in
the export stream.the export stream.

4. ●
The Indian pharmaceutical business isThe Indian pharmaceutical business is
estimated to grow at twenty per cent compoundestimated to grow at twenty per cent compound
annual growth over the forthcoming 5 years.annual growth over the forthcoming 5 years.
●
The pharmaceutical industries are rapidlyThe pharmaceutical industries are rapidly
growing in India and worldwide market.growing in India and worldwide market.
●
The domestic drug company rate was 11.9% inThe domestic drug company rate was 11.9% in
last year October 2014. highlighted the report.last year October 2014. highlighted the report.

5. http://www.ibef.org/industry/pharmaceutical-india.aspx

6. ●
There are manyThere are many bulk drugs manufacturersbulk drugs manufacturers andand
exporters in India and worldwide. The Indian bulkexporters in India and worldwide. The Indian bulk
drugs manufacturer and exporters are becomingdrugs manufacturer and exporters are becoming
global leaders in niche areas.global leaders in niche areas.
●
With a large share in the 40% worldwide bulk drugWith a large share in the 40% worldwide bulk drug
production, India the 2production, India the 2ndnd biggest bulk drug exporter,biggest bulk drug exporter,
has now declared that the winner country’s bulkhas now declared that the winner country’s bulk
drugs that cost very short are not incentive anydrugs that cost very short are not incentive any
more for the manufacturers back in India.more for the manufacturers back in India.

7. ●
The Indian Bulk Drug business is predicted toThe Indian Bulk Drug business is predicted to
grow at a CAGR of twenty first to succeed ingrow at a CAGR of twenty first to succeed in
US$16.91 billion by 2013-14 as per this study.US$16.91 billion by 2013-14 as per this study.
●
India has the number of Drug Master FilingsIndia has the number of Drug Master Filings
(DMF) amongst all key competitive economies.(DMF) amongst all key competitive economies.

8. ●
The world knows how popular China and IndiaThe world knows how popular China and India
are in manufacturing bulk drugs after beingare in manufacturing bulk drugs after being
popularly known for highly populated countriespopularly known for highly populated countries
in the world.in the world.
●
In view of the numerous growth potential of theIn view of the numerous growth potential of the
Indian bulk medicine trade, Cygnus releasesIndian bulk medicine trade, Cygnus releases
the most recent version of the Indian Bulkthe most recent version of the Indian Bulk
medicine trade Insight.medicine trade Insight.

9. Source: SFDA Southern Medicine Economic Institute

10. ●
There are manyThere are many generic drugs suppliersgeneric drugs suppliers in Indiain India
and global markets.and global markets.
●
Generic drugs are completely safe and perfectGeneric drugs are completely safe and perfect
substitute for plenty of drugs. They are alsosubstitute for plenty of drugs. They are also
approved by FDA team and already haveapproved by FDA team and already have
undergone various clinical trials to prove safety.undergone various clinical trials to prove safety.
To know more on generic drugs, you shouldTo know more on generic drugs, you should
discuss with suppliers promptly.discuss with suppliers promptly.

11. ●
The pharma market in India is unique in that it isThe pharma market in India is unique in that it is
dominated by “branded” generics which enjoy adominated by “branded” generics which enjoy a
value premium although they're not optimal tovalue premium although they're not optimal to
“unbranded” generics in either therapeutic price“unbranded” generics in either therapeutic price
or pharmacopoeia. Marketing of brandedor pharmacopoeia. Marketing of branded
generics has led to higher costs, irrational fixedgenerics has led to higher costs, irrational fixed
dose concentration as well as combinations indose concentration as well as combinations in
the pharmaceutical industry. it's time Asian nationthe pharmaceutical industry. it's time Asian nation
moved towards a de-branding of genericmoved towards a de-branding of generic
medication.medication.

13. Yash Complex,167,Kamal Park Society,Yash Complex,167,Kamal Park Society,
B/h Kapodra fire Station,Varachha Road,Surat-394211,(Gujarat), INDIAB/h Kapodra fire Station,Varachha Road,Surat-394211,(Gujarat), INDIA
Email:info@actizapharma.comEmail:info@actizapharma.com
Phone:+91 261 2572050Phone:+91 261 2572050